553 filings
Page 18 of 28
4
RSLS
ReShape Lifesciences Inc.
4 Jan 19
OBALON THERAPEUTICS / Andrew P Rasdal ownership change
6:29pm
S-1
RSLS
ReShape Lifesciences Inc.
IPO registration
4 Jan 19
5:14pm
8-K
RSLS
ReShape Lifesciences Inc.
3 Jan 19
Results of Operations and Financial Condition
9:15am
FWP
RSLS
ReShape Lifesciences Inc.
27 Dec 18
Free writing prospectus
5:12pm
424B5
RSLS
ReShape Lifesciences Inc.
27 Dec 18
Prospectus supplement for primary offering
5:04pm
8-K
RSLS
ReShape Lifesciences Inc.
27 Dec 18
Entry into a Material Definitive Agreement
4:57pm
8-K
RSLS
ReShape Lifesciences Inc.
20 Dec 18
Departure of Directors or Certain Officers
4:03pm
10-Q
2018 Q3
RSLS
ReShape Lifesciences Inc.
Quarterly report
2 Nov 18
8:16am
8-K
RSLS
ReShape Lifesciences Inc.
2 Nov 18
Obalon Announces Third Quarter 2018 Financial Results
8:01am
4
RSLS
ReShape Lifesciences Inc.
16 Oct 18
OBALON THERAPEUTICS / DAINA SCHMIDT ownership change
5:54pm
3
RSLS
ReShape Lifesciences Inc.
16 Oct 18
OBALON THERAPEUTICS / DAINA SCHMIDT ownership change
5:52pm
8-K
RSLS
ReShape Lifesciences Inc.
26 Sep 18
FDA Grants PMA-S Approval for Obalon Touchâ„¢ Inflation System
9:35am
424B3
RSLS
ReShape Lifesciences Inc.
17 Sep 18
Prospectus supplement
12:00am
EFFECT
RSLS
ReShape Lifesciences Inc.
14 Sep 18
Notice of effectiveness
12:00am
CORRESP
RSLS
ReShape Lifesciences Inc.
12 Sep 18
Correspondence with SEC
12:00am
UPLOAD
RSLS
ReShape Lifesciences Inc.
11 Sep 18
Letter from SEC
12:00am
S-3
RSLS
ReShape Lifesciences Inc.
Shelf registration
31 Aug 18
12:00am
SC 13D
RSLS
ReShape Lifesciences Inc.
31 Aug 18
Obalon Therapeutics Inc
12:00am
SC 13G/A
RSLS
ReShape Lifesciences Inc.
31 Aug 18
Obalon Therapeutics Inc
12:00am
4/A
Moatazedi David
29 Aug 18
OBALON THERAPEUTICS / DAVID MOATAZEDI ownership change
12:00am